Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
10.25
-7.16
-69.85%
Share Warrants & Outstandings
Total Reserve
68.71
63.40
5.31
8.38%
Shareholder's Funds
71.80
73.66
-1.86
-2.53%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
19.40
-19.40
-100.00%
Secured Loans
0.00
10.68
-10.68
-100.00%
Unsecured Loans
0.00
8.73
-8.73
-100.00%
Deferred Tax Assets / Liabilities
0.11
11.35
-11.24
-99.03%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.52
-1.52
-100.00%
Total Non-Current Liabilities
0.11
32.27
-32.16
-99.66%
Current Liabilities
Trade Payables
38.70
8.58
30.12
351.05%
Other Current Liabilities
0.94
3.35
-2.41
-71.94%
Short Term Borrowings
9.91
49.24
-39.33
-79.87%
Short Term Provisions
0.02
1.11
-1.09
-98.20%
Total Current Liabilities
49.58
62.28
-12.70
-20.39%
Total Liabilities
121.49
168.21
-46.72
-27.77%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
109.10
-92.25
-84.56%
Less: Accumulated Depreciation
6.37
47.13
-40.76
-86.48%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
61.97
-51.49
-83.09%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.09
-0.09
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
1.70
-0.95
-55.88%
Other Non Current Assets
3.46
0.94
2.52
268.09%
Total Non-Current Assets
18.13
96.82
-78.69
-81.27%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
16.74
21.27
127.06%
Sundry Debtors
56.54
48.50
8.04
16.58%
Cash and Bank
0.16
3.08
-2.92
-94.81%
Other Current Assets
0.17
1.19
-1.02
-85.71%
Short Term Loans and Advances
8.13
1.88
6.25
332.45%
Total Current Assets
103.36
71.39
31.97
44.78%
Net Current Assets (Including Current Investments)
53.78
9.11
44.67
490.34%
Total Current Assets Excluding Current Investments
103.00
71.39
31.61
44.28%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
168.21
-46.72
-27.77%
Contingent Liabilities
0.00
1.95
-1.95
-100.00%
Total Debt
9.91
68.64
-58.73
-85.56%
Book Value per share (adjusted)
232.39
55.51
176.88
318.65%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024






